Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets.

In autoimmune type 1 diabetes, Fas-to-Fas-ligand (FasL) interaction may represent one of the essential pro-apoptotic pathways leading to a loss of pancreatic beta-cells. In the advanced stages of type 2 diabetes, a decline in beta-cell mass is also observed, but its mechanism is not known. Human islets normally express FasL but not the Fas receptor. We observed upregulation of Fas in beta-cells of type 2 diabetic patients relative to nondiabetic control subjects. In vitro exposure of islets from nondiabetic organ donors to high glucose levels induced Fas expression, caspase-8 and -3 activation, and beta-cell apoptosis. The effect of glucose was blocked by an antagonistic anti-Fas antibody, indicating that glucose-induced apoptosis is due to interaction between the constitutively expressed FasL and the upregulated Fas. These results support a new role for glucose in regulating Fas expression in human beta-cells. Upregulation of the Fas receptor by elevated glucose levels may contribute to beta-cell destruction by the constitutively expressed FasL independent of an autoimmune reaction, thus providing a link between type 1 and type 2 diabetes.

[1]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[2]  J. Hanke.  Apoptosis and occurrence of Bcl-2, Bak, Bax, Fas and FasL in the developing and adult rat endocrine pancreas , 2000, Anatomy and Embryology.

[3]  J. Gerich.  Insulin resistance is not necessarily an essential component of type 2 diabetes. , 2000, The Journal of clinical endocrinology and metabolism.

[4]  S. Bonner-Weir.  Islet growth and development in the adult. , 2000, Journal of molecular endocrinology.

[5]  G. Salvesen,et al.  Caspases - controlling intracellular signals by protease zymogen activation. , 2000, Biochimica et biophysica acta.

[6]  Y. Matsuzawa,et al.  Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus , 1999, Diabetologia.

[7]  J. Corbett,et al.  Evidence that beta cell death in the nonobese diabetic mouse is Fas independent. , 1999, Journal of immunology.

[8]  F. Bertuzzi,et al.  Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. , 1999, Diabetes.

[9]  E. Cerasi,et al.  Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. , 1999, Diabetes.

[10]  B. Zhivotovsky,et al.  Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration. , 1998, The Journal of biological chemistry.

[11]  A. Strasser,et al.  Mechanisms of beta cell death in diabetes: a minor role for CD95. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Augstein,et al.  Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes , 1998, Diabetologia.

[13]  N. Morgan,et al.  Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation. , 1998, Diabetes.

[14]  D. Smith,et al.  Technical note: Aberrant detection of cell surface Fas ligand with anti-peptide antibodies. , 1998, Journal of immunology.

[15]  J. Tschopp,et al.  Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity , 1998, The Journal of experimental medicine.

[16]  K. Polonsky,et al.  Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. , 1998, Diabetes.

[17]  G. Stassi,et al.  Nitric Oxide Primes Pancreatic β Cells for Fas-mediated Destruction in Insulin-dependent Diabetes Mellitus , 1997, The Journal of experimental medicine.

[18]  Y. Matsuzawa,et al.  Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice , 1997, The Journal of experimental medicine.

[19]  C. Ricordi,et al.  Improved Human Islet Isolation Using a New Enzyme Blend, Liberase , 1997, Diabetes.

[20]  D. Allan,et al.  Apoptosis Is the Mode of β-Cell Death Responsible for the Development of IDDM in the Nonobese Diabetic (NOD) Mouse , 1997, Diabetes.

[21]  C. Janeway,et al.  The Role of Fas in Autoimmune Diabetes , 1997, Cell.

[22]  L. Bouwens,et al.  Proliferation and differentiation in the human fetal endocrine pancreas , 1997, Diabetologia.

[23]  M. Kurrer,et al.  Beta cell apoptosis in T cell-mediated autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Yamada,et al.  Mouse islet cell lysis mediated by interleukin-1-induced Fas , 1996, Diabetologia.

[25]  D. Pipeleers,et al.  Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. , 1996, The Journal of clinical investigation.

[26]  J. Sturis,et al.  Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. , 1996, The New England journal of medicine.

[27]  M. Todaro,et al.  Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human beta-cells sorted by flow-cytometry and cultured in vitro. , 1995, Transplantation proceedings.

[28]  M. Weller,et al.  Fas/APO-1 gene transfer for human malignant glioma. , 1995, Cancer research.

[29]  D. Accili,et al.  Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM? , 1994, Diabetes.

[30]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[31]  E. Cerasi,et al.  Monolayer culture of adult rat pancreatic islets on extracellular matrix: modulation of B-cell function by chronic exposure to high glucose. , 1991, Endocrinology.

[32]  J. Leahy,et al.  Compensatory Growth of Pancreatic β-Cells in Adult Rats After Short-Term Glucose Infusion , 1989, Diabetes.

[33]  R. Holman,et al.  Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. , 1988, Diabetes research.

[34]  Tohru Takahashi,et al.  Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects. , 1979, The Tohoku journal of experimental medicine.

[35]  K. Maedler,et al.  Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. , 2001, Diabetes.

[36]  M. Löhr,et al.  Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. , 1985, Survey and synthesis of pathology research.